Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Can the Gut Microbiome be the Answer to Personalized Healthcare?

Gut health awareness has been playing a pivotal role in the improvement of health as more and more people begin to prioritize the state of microbiome in their bodies. Health experts say that the gut provides an answer to someone’s health, particularly, their digestion and mood, according to Hopkins Medicine. Additionally, the body’s immune system…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Highway to Health on MarketScale.

Share

Gut health awareness has been playing a pivotal role in the improvement of health as more and more people begin to prioritize the state of microbiome in their bodies. Health experts say that the gut provides an answer to someone’s health, particularly, their digestion and mood, according to Hopkins Medicine. Additionally, the body’s immune system is interconnected with the gut, as up to 80 percent of immune cells are located in the gut. The growing focus on this unique area of health is why concepts like precise healthcare are becoming more common. It is also why the microbiome is prioritized in the idea that led to the creation of Day Two — a comprehensive and personalized microbiome-based health plan.

So, how does emphasizing precision in healthcare benefit patients and how is microbiome the key to that?

The Chief Medical Officer of Day Two, Aamir Rehman, discussed this on the latest episode of “Highway to Health” with host David Kemp. Rehman also delved into how Day Two the step towards unique care that is specific to a person’s needs.

Kemp and Rehman further discussed …

  1. How Day Two functions and provides health professionals with individualized information based on a person’s microbiome
  2. How the gut’s microbiome is used to determine a specific health plan
  3. Why precise healthcare can command and provide the best solutions for any given condition and healthy lifestyle

“If you can create personalization and precision for people, that is probably one of the most important things that allows them greater control over their health. Because one, they have confidence that the science that is precise to them and hopefully it will make a difference, and then two, they can figure out how best to comply with it,” said Rehman.

Amir Rehman is a Physician Executive and the Chief Medical Officer the Day Two. He is also the Executive Clinical and Commercial Advisor at Clinical Innovation and Strategy Advisors and has held senior positions in healthcare organizations for more than a decade.

Highway to Health

Part of this channel

Highway to Health

Healthcare innovation conversations for executives and technology buyers.

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512